Security key
774374300
ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI)
CUSIP: 774374300
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 89,116,466
- Total 13F shares
- 5,122,253
- Share change
- -70,578
- Total reported value
- $9,681,434
- Put/Call ratio
- 141%
- Price per share
- $1.89
- Number of holders
- 32
- Value change
- -$174,611
- Number of buys
- 18
- Number of sells
- 14
Report period
Q4 2023
Institutions
32
Top holders
10
RMTI full security history
Newer quarter: Q1 2024
Previous quarter: Q3 2023
ROCKWELL MEDICAL, INC. SEC filings
ROCKWELL MEDICAL, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 774374300
Recent filing periods:
Top shareholders of RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.2%
|
2,817,000
|
$5,859,360 | — | 30 Sep 2023 | |
| Richmond Brothers, Inc. |
13F
|
Company |
0.46%
|
410,352
|
$853,535 | — | 30 Sep 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.42%
|
376,815
|
$783,775 | — | 30 Sep 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.27%
|
243,008
|
$505,611 | — | 30 Sep 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.27%
|
241,901
|
$503,154 | — | 30 Sep 2023 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.21%
|
190,670
|
$396,594 | — | 30 Sep 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.2%
|
178,555
|
$371,394 | — | 30 Sep 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.17%
|
149,981
|
$311,961 | — | 30 Sep 2023 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.15%
|
134,200
|
$279,000 | — | 30 Sep 2023 | |
| John Peter Mclaughlin |
3/4/5
|
Director |
—
mixed-class rows
|
209,831
mixed-class rows
|
$191,764 | — | 17 Jun 2021 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.08%
|
75,043
|
$156,000 | — | 30 Sep 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.07%
|
63,732
|
$132,563 | — | 30 Sep 2023 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.07%
|
60,286
|
$125,395 | — | 30 Sep 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
33,959
|
$70,635 | — | 30 Sep 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
33,604
|
$69,896 | — | 30 Sep 2023 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.04%
|
32,720
|
$68,000 | — | 30 Sep 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
26,123
|
$54,336 | — | 30 Sep 2023 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.02%
|
21,100
|
$43,888 | — | 30 Sep 2023 | |
| SkyOak Wealth, LLC |
13F
|
Company |
0.02%
|
19,545
|
$40,654 | — | 30 Sep 2023 | |
| Paul E. McGarry |
3/4/5
|
SVP, Finance and CAO |
—
mixed-class rows
|
65,725
mixed-class rows
|
$39,921 | — | 17 Mar 2023 | |
| GREAT VALLEY ADVISOR GROUP, INC. |
13F
|
Company |
0.02%
|
17,961
|
$37,359 | — | 30 Sep 2023 | |
| Marc L. Hoffman |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
58,655
mixed-class rows
|
$35,931 | — | 17 Mar 2023 | |
| Cetera Advisor Networks LLC |
13F
|
Company |
0.02%
|
14,127
|
$29,384 | — | 30 Sep 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
14,043
|
$29,000 | — | 30 Sep 2023 | |
| SIGMA INVESTMENT COUNSELORS INC |
13F
|
Company |
0.01%
|
12,927
|
$26,889 | — | 30 Sep 2023 | |
| Bayesian Capital Management, LP |
13F
|
Company |
0.01%
|
10,500
|
$21,840 | — | 30 Sep 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
7,611
|
$15,830 | — | 30 Sep 2023 | |
| UBS Group AG |
13F
|
Company |
0%
|
3,850
|
$8,008 | — | 30 Sep 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,898
|
$3,948 | — | 30 Sep 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
798
|
$1,660 | — | 30 Sep 2023 | |
| Rise Advisors, LLC |
13F
|
Company |
0%
|
215
|
$447 | — | 30 Sep 2023 | |
| COMERICA BANK |
13F
|
Company |
0%
|
163
|
$339 | — | 30 Sep 2023 | |
| Stonebridge Capital Advisors LLC |
13F
|
Company |
0%
|
109
|
$227 | — | 30 Sep 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
65
|
$135 | — | 30 Sep 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
35
|
$73 | — | 30 Sep 2023 | |
| Russell H. Ellison |
3/4/5
|
President and Chief Executive Officer, Director |
—
class O/S missing
|
200,000
|
— | — | 03 May 2021 | |
| Raymond Dennis Pratt |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
112,500
|
— | — | 03 May 2021 | |
| Russell Skibsted |
3/4/5
|
EVP, Chief Financial Officer and Chief Business Officer |
—
class O/S missing
|
80,000
|
— | — | 09 Sep 2022 |
Institutional Holders of ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) as of Q4 2023
As of 31 Dec 2023,
ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,122,253 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Richmond Brothers, Inc., PERKINS CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, RAYMOND JAMES & ASSOCIATES, BlackRock Inc., MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
31
Q4 2023 holders
32
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.